The move toward infusion centers as the preferred site of care is not a short-term response. It aligns with broader industry trends, including specialty drug pipelines that continue to favor infused biologics and a sustained rise in infusion demand.
The post Why Hospital Outpatient Isn’t the Default for Long-Term Infusion Anymore appeared first on MedCity News.
